Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bovine IgG for CS17-ETEC Diarrhea Prevention
NCT00524004Phase 2Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Jan 2007
- Primary completion
- Oct 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of anti-csbD bovine immunoglobulin G, anti-cs17 bovine igg in traveler's diarrhea (TD), sponsored by Johns Hopkins Bloomberg School of Public Health. Started Jan 2007; status: completed.
02
Drugs
anti-csbD bovine immunoglobulin Ganti-cs17 bovine igg
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00524004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524004.